期刊文献+

雷珠单抗玻璃体腔注射联合眼底激光治疗糖尿病性黄斑水肿的效果观察 被引量:8

Observation on the Effect of Intravitreal Injection of Ranibizumab Combined with Fundus Laser in Treatment of Diabetic Macular Edema
下载PDF
导出
摘要 目的:观察雷珠单抗玻璃体腔注射联合眼底激光治疗糖尿病性黄斑水肿的效果。方法:选取本院收治的糖尿病性黄斑水肿患者700例(700眼),按照随机数字表法分为对照组、试验组,各350例(350眼)。对照组给予激光光凝治疗,试验组在对照组基础上加用雷珠单抗玻璃体腔注射。比较两组黄斑水肿消退情况、最佳矫正视力及并发症情况。结果:治疗后,试验组水肿消退95.14%,高于对照组的90.86%(P<0.05);试验组视力提高、视力不变发生率均高于对照组,视力下降发生率低于对照组,差异均有统计学意义(P<0.05);试验组并发症发生率为3.43%,显著低于对照组的8.86%(P<0.05)。结论:相比单纯使用激光光凝治疗,雷珠单抗玻璃体腔注射联合眼底激光治疗糖尿病性黄斑水肿的疗效显著,可快速有效地吸收黄斑水肿,提高患者视力水平,降低并发症发生率,值得在临床上推广使用。 Objective:To observe the effect of intravitreal injection of Ranibizumab combined with fundus laser in treatment of diabetic macular edema.Method:A total of 700 patients(700 eyes)with diabetic macular edema admitted to our hospital were selected.According to the random number table method,they were divided into control group and experimental group,350 cases(350 eyes)in each group.The control group was treated with laser photocoagulation,and the experimental group was treated with intravitreal injection of Ranibizumab on the basis of the control group.The regression of macular edema,best corrected visual acuity and complications were compared between the two groups.Result:After treatment,edema subsided by 95.14%in the experimental group,which was higher than 90.86%in the control group(P<0.05).The incidence of visual acuity improvement and visual acuity invariability in the experimental group were higher than those in the control group,and the incidence of visual acuity decline was lower than that in the control group,the differences were statistically significant(P<0.05).The incidence of complications in the experimental group was 3.43%,which was significantly lower than 8.86%in the control group(P<0.05).Conclusion:Compared with laser photocoagulation alone,Ranibizumab intravitreal injection combined with fundus laser is effective in treatment of diabetic macular edema,it can absorb macular edema quickly and effectively,improve the visual acuity of patients,and reduce the incidence of complications,which is worth popularizing in clinical practice.
作者 王江敏 李东正 王君辉 WANG Jiangmin;LI Dongzheng;WANG Junhui(Sanmenxia Hospital of the Yellow River, Sanmenxia 472000, China)
出处 《中国医学创新》 CAS 2019年第30期58-61,共4页 Medical Innovation of China
关键词 雷珠单抗 联合治疗 玻璃体腔注射 眼底激光 糖尿病性黄斑水肿 Ranibizumab Combination therapy Intravitreal injection Fundus laser Diabetic macular edema
  • 相关文献

参考文献16

二级参考文献169

  • 1齐慧君,黎晓新.不同分期糖尿病视网膜病变激光治疗预后分析[J].中国实用眼科杂志,2004,22(10):801-803. 被引量:65
  • 2范琳,徐夏冰,刘志旭.Gyc-2000激光光凝术联合复方樟柳碱颞旁皮下注射治疗糖尿病视网膜病变[J].中国厂矿医学,2005,18(4):312-313. 被引量:6
  • 3喻晓兵,师自安,戴虹,龙力.曲安奈德玻璃体注射治疗视网膜分支静脉阻塞继发黄斑水肿[J].中国实用眼科杂志,2006,24(10):1043-1045. 被引量:13
  • 4葛坚.眼科学[M].北京:人民卫生出版社,2010:139-140.
  • 5赵堪兴,杨培增.眼科学[M].北京:人民卫生出版社,2013:282.
  • 6Pelzek C, Lim JI.Diabetic macular edema: review and update [J]. Ophthalmol Clin North Am,2002,15(4):555-563.
  • 7Aiello LM.Perspectives on diabetic retinopathy[J]. Am J Oph- thalmol, 2003,136( 1 ) : 122-135.
  • 8Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema[J]. Arch Ophthal- mol, 1985,103(12) : 1796-1806.
  • 9Early Treatment Diabetic Retinopathy Study Research Group.Fo- cal photocoagulation treatment of diabetic macular edema [J]. Arch Ophthalmol, 1995,113(9) : 1144-1155.
  • 10Shimura M, Yasuda K, Nakazawa T, et al. Quantifying altera- tions of macular thickness before and after panretinal photoco- agulation in patients with severe diabetic retinopathy and good vision[J]. Ophthalmology,2003,110(12) :2386-2394.

共引文献272

同被引文献93

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部